Healthy high growth potential

Results

1529

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1529 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
AXSM
US$213.681.7%96.5%US$11.2bUS$285.4214.461.2%n/aPharmaceuticals & Biotech
MDGL
US$507.37-0.6%36.6%US$12.4bUS$678.069.163.7%n/aPharmaceuticals & Biotech
FWRY
ج.م19.01-1.2%44.0%ج.م64.8bج.م22.4524.327.3%n/aDiversified Financials
NVDA
US$225.302.9%23.8%US$5.4tUS$302.8334.222.8%0.4%Semiconductors
LITE
US$880.415.1%668.1%US$82.6bUS$1,148.3025.9104.4%n/aTech
CRDO
US$265.9915.4%126.7%US$50.0bUS$279.29105.027.7%n/aSemiconductors
MOD
US$203.515.7%45.9%US$10.6bUS$310.2975.051.3%n/aCapital Goods
TGTX
US$47.94-3.2%72.6%US$7.0bUS$69.7115.421.3%n/aPharmaceuticals & Biotech
SAUD3
R$13.72-3.3%7.2%R$40.1bR$17.6938.131.9%5.9%Healthcare
509496
₹1,299.157.4%69.2%₹223.2b₹1,589.6737.129.9%0.2%Capital Goods
6223
NT$6,440.005.6%413.1%NT$631.0bNT$8,430.00137.861.8%0.3%Semiconductors
600183
CN¥143.212.3%219.5%CN¥347.9bCN¥146.5888.529.6%1.1%Tech
688192
CN¥60.918.8%-28.5%CN¥28.3bCN¥83.0031.7104.5%n/aPharmaceuticals & Biotech
002810
CN¥20.13-0.5%47.5%CN¥7.0bCN¥36.0034.943.1%2.0%Materials
002970
CN¥52.371.9%11.4%CN¥9.5bn/a29.336.5%1.9%Automobiles
688183
CN¥115.99-2.3%111.3%CN¥96.1bCN¥159.0056.035.5%0.8%Tech
688072
CN¥688.20-0.4%314.1%CN¥199.2bCN¥681.93121.146.8%0.05%Semiconductors
688700
CN¥57.82-7.9%23.0%CN¥17.2bCN¥61.6797.061.7%0.3%Capital Goods
543273
₹2,731.508.2%228.1%₹69.3b₹2,500.0087.953.9%n/aTransportation
3036
NT$210.00-0.7%67.3%NT$266.5bNT$314.8610.928.9%3.7%Tech
2480
HK$13.10-3.7%-44.3%HK$2.6bHK$31.003.477.1%n/aPharmaceuticals & Biotech
SCHNEIDER
₹1,369.201.1%57.2%₹327.4b₹1,398.33154.034.0%n/aCapital Goods
6787
JP¥18,250.00-2.9%128.7%JP¥468.4bJP¥28,400.0023.830.1%0.9%Tech
002975
CN¥99.992.1%159.7%CN¥20.8bCN¥130.0089.444.2%0%Tech
Page 1 of 43
Healthy high growth potential - Investing Ideas - Simply Wall St